Log in | Register

Clinical spectrum and short-term outcome of adult patients with purpura fulminans: a French multicenter retrospective cohort study

Damien Contou| Romain Sonneville| Florence Canoui-Poitrine| Gwenhaël Colin| Rémi Coudroy| Frédéric Pène| Jean-Marc Tadié| Martin Cour| Gaëtan Béduneau| Antoine Marchalot| Laurent Guérin| Sébastien Jochmans| Stephan Ehrmann| Nicolas Terzi| Sébastien Préau| François Barbier| Guillaume Schnell| Damien Roux| Olivier Leroy| Claire Pichereau| Elodie Gélisse| Lara Zafrani| Richard Layese| Christian Brun-
Original
Volume 44, Issue 9 / September , 2018

Pages 1502 - 1511

Abstract

Purpose

Data on purpura fulminans (PF) in adult patients are scarce and mainly limited to meningococcal infections. Our aim has been to report the clinical features and outcomes of adult patients admitted in the intensive care unit (ICU) for an infectious PF, as well as the predictive factors for limb amputation and mortality.

Methods

A 17-year national multicenter retrospective cohort study in 55 ICUs in France from 2000 to 2016, including adult patients admitted for an infectious PF defined by a sudden and extensive purpura, together with the need for vasopressor support. Primary outcome variables included hospital mortality and amputation during the follow-up period (time between ICU admission and amputation, death or end of follow-up).

Results

Among the 306 included patients, 126 (41.2%; 95% CI 35.6–46.9) died and 180 (58.8%; 95% CI 53.3–64.3) survived during the follow-up period [13 (3–24) days], including 51/180 patients (28.3%, 95% CI 21.9–35.5) who eventually required limb amputations, with a median number of 3 (1–4) limbs amputated. The two predominantly identified microorganisms were Neisseria meningitidis (63.7%) and Streptococcus pneumoniae (21.9%). By multivariable Cox model, SAPS II [hazard-ratio (HR) = 1.03 (1.02–1.04); p < 0.001], lower leucocytes [HR 0.83 (0.69–0.99); p = 0.034] and platelet counts [HR 0.77 (0.60–0.91); p = 0.007], and arterial blood lactate levels [HR 2.71 (1.68–4.38); p < 0.001] were independently associated with hospital death, while a neck stiffness [HR 0.51 (0.28–0.92); p = 0.026] was a protective factor. Infection with Streptococcus pneumoniae [sub-hazard ratio 1.89 (1.06–3.38); p = 0.032], together with arterial lactate levels and ICU admission temperature, was independently associated with amputation by a competing risks analysis.

Conclusion

Purpura fulminans carries a high mortality and morbidity. Pneumococcal PF leads to a higher risk of amputation.

Trials registration

NCT03216577.

Keywords

References

  1. Vincent JL, Nadel S, Kutsogiannis DJ, Gibney RT, Yan SB, Wyss VL, Bailey JE, Mitchell CL, Sarwat S, Shinall SM, Janes JM (2005) Drotrecogin alfa (activated) in patients with severe sepsis presenting with purpura fulminans, meningitis, or meningococcal disease: a retrospective analysis of patients enrolled in recent clinical studies. Crit Care 9:R331–R343
    • View reference on publisher's website
    • View reference on PubMed
  2. Lerolle N, Carlotti A, Melican K, Aubey F, Pierrot M, Diehl JL, Caille V, Hekimian G, Gandrille S, Mandet C, Bruneval P, Dumenil G, Borgel D (2013) Assessment of the interplay between blood and skin vascular abnormalities in adult purpura fulminans. Am J Respir Crit Care Med 188:684–692
    • View reference on publisher's website
    • View reference on PubMed
  3. Fitzgerald CJ, Pranikoff TV, Ross GA, Mou S, Givner LB, Shetty AK (2011) Purpura fulminans caused by community-associated methicillin-resistant Staphylococcus aureus. Am J Emerg Med 30(1013):e1011–e1014
  4. Kravitz GR, Dries DJ, Peterson ML, Schlievert PM (2005) Purpura fulminans due to Staphylococcus aureus. Clin Infect Dis 40:941–947
    • View reference on publisher's website
    • View reference on PubMed
  5. Renaud C, Ovetchkine P, Bortolozzi P, Saint-Cyr C, Tapiero B (2010) Fatal group A Streptococcus purpura fulminans in a child receiving TNF-alpha blocker. Eur J Pediatr 170:657–660
    • View reference on publisher's website
    • View reference on PubMed
  6. Giraud T, Dhainaut JF, Schremmer B, Regnier B, Desjars P, Loirat P, Journois D, Lanore JJ (1991) Adult overwhelming meningococcal purpura. A study of 35 cases, 1977–1989. Arch Intern Med 151:310–316
    • View reference on publisher's website
    • View reference on PubMed
  7. Maat M, Buysse CM, Emonts M, Spanjaard L, Joosten KF, de Groot R, Hazelzet JA (2007) Improved survival of children with sepsis and purpura: effects of age, gender, and era. Crit Care 11:R112
    • View reference on publisher's website
    • View reference on PubMed
  8. Kornelisse RF, Hazelzet JA, Hop WC, Spanjaard L, Suur MH, van der Voort E, de Groot R (1997) Meningococcal septic shock in children: clinical and laboratory features, outcome, and development of a prognostic score. Clin Infect Dis 25:640–646
    • View reference on publisher's website
    • View reference on PubMed
  9. Derkx B, Wittes J, McCloskey R (1999) Randomized, placebo-controlled trial of HA-1A, a human monoclonal antibody to endotoxin, in children with meningococcal septic shock. European Pediatric Meningococcal Septic Shock Trial Study Group. Clin Infect Dis 28:770–777
    • View reference on publisher's website
    • View reference on PubMed
  10. Thompson MJ, Ninis N, Perera R, Mayon-White R, Phillips C, Bailey L, Harnden A, Mant D, Levin M (2006) Clinical recognition of meningococcal disease in children and adolescents. Lancet 367:397–403
    • View reference on publisher's website
    • View reference on PubMed
  11. White B, Livingstone W, Murphy C, Hodgson A, Rafferty M, Smith OP (2000) An open-label study of the role of adjuvant hemostatic support with protein C replacement therapy in purpura fulminans-associated meningococcemia. Blood 96:3719–3724
    • View reference on PubMed
  12. Levin M, Quint PA, Goldstein B, Barton P, Bradley JS, Shemie SD, Yeh T, Kim SS, Cafaro DP, Scannon PJ, Giroir BP (2000) Recombinant bactericidal/permeability-increasing protein (rBPI21) as adjunctive treatment for children with severe meningococcal sepsis: a randomised trial. rBPI21 Meningococcal Sepsis Study Group. Lancet 356:961–967
    • View reference on publisher's website
    • View reference on PubMed
  13. Rintala E, Kauppila M, Seppala OP, Voipio-Pulkki LM, Pettila V, Rasi V, Kotilainen P (2000) Protein C substitution in sepsis-associated purpura fulminans. Crit Care Med 28:2373–2378
    • View reference on publisher's website
    • View reference on PubMed
  14. Le Gall JR, Lemeshow S, Saulnier F (1993) A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 270:2957–2963
    • View reference on publisher's website
    • View reference on PubMed
  15. Vincent JL, Moreno R, Takala J, Willatts S, De Mendonca A, Bruining H, Reinhart CK, Suter PM, Thijs LG (1996) The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 22:707–710
  16. Zeerleder S, Stephan F, Emonts M, de Kleijn ED, Esmon CT, Varadi K, Hack CE, Hazelzet JA (2012) Circulating nucleosomes and severity of illness in children suffering from meningococcal sepsis treated with protein C. Crit Care Med 40:3224–3229
    • View reference on publisher's website
    • View reference on PubMed
  17. Hazelzet JA (2005) Diagnosing meningococcemia as a cause of sepsis. Pediatr Crit Care Med 6:S50–S54
    • View reference on publisher's website
    • View reference on PubMed
  18. Guiddir T, Gros M, Hong E, Terrade A, Denizon M, Deghmane AE, Taha MK (2018) Unusual initial abdominal presentations of invasive meningococcal disease. Clin Infect Dis. https://doi.org/10.1093/cid/ciy257
    • View reference on PubMed
  19. Theilacker C, Ludewig K, Serr A, Schimpf J, Held J, Bogelein M, Bahr V, Rusch S, Pohl A, Kogelmann K, Frieseke S, Bogdanski R, Brunkhorst FM, Kern WV (2016) Overwhelming postsplenectomy infection: a prospective multicenter cohort study. Clin Infect Dis 62:871–878
    • View reference on publisher's website
    • View reference on PubMed
  20. Cartwright KA (1999) Early management of meningococcal disease. Infect Dis Clin N Am 13:661–684 (viii)
    • View reference on publisher's website
  21. Barquet N, Domingo P, Cayla JA, Gonzalez J, Rodrigo C, Fernandez-Viladrich P, Moraga-Llop FA, Marco F, Vazquez J, Saez-Nieto JA, Casal J, Canela J, Foz M (1999) Meningococcal disease in a large urban population (Barcelona, 1987–1992): predictors of dismal prognosis. Barcelona Meningococcal Disease Surveillance Group. Arch Intern Med 159:2329–2340
    • View reference on publisher's website
    • View reference on PubMed
  22. Cartwright K, Reilly S, White D, Stuart J (1992) Early treatment with parenteral penicillin in meningococcal disease. BMJ 305:143–147
    • View reference on publisher's website
    • View reference on PubMed
  23. Sorensen HT, Nielsen GL, Schonheyder HC, Steffensen FH, Hansen I, Sabroe S, Dahlerup JF, Hamburger H, Olsen J (1998) Outcome of pre-hospital antibiotic treatment of meningococcal disease. J Clin Epidemiol 51:717–721
    • View reference on publisher's website
    • View reference on PubMed
  24. Mikkelsen ME, Miltiades AN, Gaieski DF, Goyal M, Fuchs BD, Shah CV, Bellamy SL, Christie JD (2009) Serum lactate is associated with mortality in severe sepsis independent of organ failure and shock. Crit Care Med 37:1670–1677
    • View reference on publisher's website
    • View reference on PubMed
  25. Periappuram M, Taylor MR, Keane CT (1995) Rapid detection of meningococci from petechiae in acute meningococcal infection. J Infect 31:201–203
    • View reference on publisher's website
    • View reference on PubMed
  26. van Deuren M, van Dijke BJ, Koopman RJ, Horrevorts AM, Meis JF, Santman FW, van der Meer JW (1993) Rapid diagnosis of acute meningococcal infections by needle aspiration or biopsy of skin lesions. BMJ 306:1229–1232
    • View reference on publisher's website
    • View reference on PubMed
  27. de Risi-Pugliese T, Servy A, Decousser JW, Nebbad B, Desroches M, Wolkenstein P, de Prost N, Chosidow O (2017) Skin biopsy polymerase chain reaction for rapid microbiological diagnosis in patients with purpura fulminans. Br J Dermatol 177:e154–e155
    • View reference on publisher's website
    • View reference on PubMed

Sign In

Connect with ICM

Top 5 Articles Editors Picks Supplement